These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4427392)

  • 1. Graft versus leukemia: effect of phytohemagglutinin-stimulated and normal spleen cells on Rauscher disease.
    Lair SV; Lozzio BB
    J Natl Cancer Inst; 1974 Oct; 53(4):1165-8. PubMed ID: 4427392
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of erythroleukemia in Rauscher virus infected mice treated with phytohemagglutinin.
    Lozzio BB; Brown A; Hewins JP
    Exp Hematol; 1974; 2(1):16-27. PubMed ID: 4532081
    [No Abstract]   [Full Text] [Related]  

  • 3. [A peculiarity in the humoral immunity of BALB/C mice with Rauscher leukemia].
    Sokolov PP; Bergol'ts VM
    Biull Eksp Biol Med; 1976 Mar; 81(3):356-8. PubMed ID: 1085178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of murine lymphocytes by Rauscher leukemia virus in vitro.
    Bubbers JE; Elder JH; Dixon FJ
    J Immunol; 1980 Jan; 124(1):388-94. PubMed ID: 7350233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of cellular and humoral immunity in mice infected with Rauscher leukemia virus following administration of serum against isologous aggregated immunoglobulins].
    Snegireva AE; Khorobrykh VV; Kaulen DR; Merimskaia OS; Shevliagin VIa
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1980; (7):27-33. PubMed ID: 6967739
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral leukemogenesis in immunologically and hematologically altered mice.
    Sinkovics JG; Ahearn MJ; Shirato E; Shullenberger CC
    J Reticuloendothel Soc; 1970 Nov; 8(5):474-92. PubMed ID: 4319518
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of phytohemagglutinin- and alloantigen-induced lymphocyte stimulation by Rauscher leukemia virus.
    Häyry P; Rago D; Defendi V
    J Natl Cancer Inst; 1970 Jun; 44(6):1311-9. PubMed ID: 11515452
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrasting immune response following Rauscher Leukemia virus infection in virus-susceptible vs. virus-resistant mice.
    Meredith RF; Okunewick JP; Brozovich BJ; Weaver EV
    Dev Comp Immunol; 1978 Feb; 2(1):133-46. PubMed ID: 305865
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of leukemogenic and immunogenic properties of leukemic cells modified by neuraminidase of non-cholera Vibrios on the model of Rauscher leukemia].
    Bratus GG; Darchuk GF
    Eksp Onkol; 1985; 7(2):56-60. PubMed ID: 3874054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic stimuli in relation to leukemogenesis. 1. Potentiation of Rauscher viral leukemia by Freund's adjuvants.
    Siegel BV; Morton JI
    J Natl Cancer Inst; 1972 Jun; 48(6):1681-5. PubMed ID: 4560295
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity of splenocytes, associated with temporal exposition of D-galactosyl residues, in Rauscher leukemia.
    Novichenko NL
    Arch Geschwulstforsch; 1984; 54(4):279-84. PubMed ID: 6497576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemotherapy of transplantable Moloney leukemia with cyclophosphamide and allogeneic spleen lymphocytes and reversal of graft-versus-host disease with alloantiserum.
    Kende M; Keys LD; Gaston M; Goldin A
    Cancer Res; 1975 Feb; 35(2):346-51. PubMed ID: 234033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the pathodynamics of proliferative processes in the spleen of NMRI-mice during the early phase of Rauscher leukemia].
    Komitowski D; Goerttler K
    Exp Pathol (Jena); 1974; 9(3):182-90. PubMed ID: 4435093
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytotoxic and blocking antibodies in the sera and eluates from spleen cells of mice with Rauscher leukemia following a different course].
    Ter-Grigorov VS; Dzagurov SG; Shevelev BI
    Biull Eksp Biol Med; 1975 Feb; 79(2):76-80. PubMed ID: 48386
    [No Abstract]   [Full Text] [Related]  

  • 15. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolation of 7S-immunoglobulins (IgG), detected in spleen cells and sera of mice in the early stages of Rauscher leukemia].
    Ter-Grigorov VS; Dzagurov SG; Dorfman NA; Shevelev BI
    Biull Eksp Biol Med; 1974 Nov; 78(11):82-5. PubMed ID: 4614878
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
    J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro.
    Hirsch MS; Phillips SM; Solnik C; Black PH; Schwartz RS; Carpenter CB
    Proc Natl Acad Sci U S A; 1972 May; 69(5):1069-72. PubMed ID: 4402535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histoproliferative effect of Rauscher leukemia virus on lymphatic tissue: histological and ultrastructural studies of germinal centers and their relation to leukemogenesis.
    Hanna MG; Szakal AK; Tyndall RL
    Cancer Res; 1970 Jun; 30(6):1748-63. PubMed ID: 5457938
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccination with a live retrovirus: the nature of the protective immune response.
    Ruprecht RM; Mullaney S; Bernard LD; Gama Sosa MA; Hom RC; Finberg RW
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5558-62. PubMed ID: 2371289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.